Insider Selling: STERIS (NYSE:STE) VP Sells 2,046 Shares of Company Stock

Key Points

  • STERIS VP Julia Madsen sold 2,046 shares for $531,960 at an average price of $260, reducing her direct stake by 16.69% to 10,211 shares.
  • STERIS beat quarterly earnings and revenue estimates: EPS was $2.94 versus $2.68 expected, while revenue rose 8.8% year over year to $1.59 billion.
  • The company declared a quarterly dividend of $0.69 per share. Analysts’ consensus rating is Moderate Buy, with a consensus price target of $283.50.

STERIS plc (NYSE:STE - Get Free Report) VP Julia Madsen sold 2,046 shares of the stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $260.00, for a total transaction of $531,960.00. Following the completion of the transaction, the vice president directly owned 10,211 shares of the company's stock, valued at $2,654,860. The trade was a 16.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

STERIS Stock Down 1.7%

STE stock opened at $257.42 on Wednesday. The firm has a 50 day moving average of $224.80 and a 200 day moving average of $224.59. The stock has a market capitalization of $25.00 billion, a PE ratio of 24.05 and a beta of 0.86. The company has a quick ratio of 1.44, a current ratio of 2.05 and a debt-to-equity ratio of 0.23. STERIS plc has a 52 week low of $195.14 and a 52 week high of $269.44.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.26. STERIS had a net margin of 13.41% and a return on equity of 14.80%. The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm earned $2.47 EPS. STERIS's revenue was up 8.8% compared to the same quarter last year. Sell-side analysts forecast that STERIS plc will post 11.46 earnings per share for the current year.

STERIS Announces Dividend




The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be paid a dividend of $0.69 per share. This represents a $2.76 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, November 17th. STERIS's payout ratio is presently 32.74%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen raised shares of STERIS from a "buy" rating to a "strong-buy" rating in a report on Saturday. UBS Group cut their target price on STERIS from $275.00 to $270.00 and set a "buy" rating on the stock in a research report on Friday, August 7th. Jefferies Financial Group upgraded STERIS from a "hold" rating to a "buy" rating and raised their target price for the stock from $232.00 to $305.00 in a research note on Friday. KeyCorp lifted their price target on STERIS from $269.00 to $284.00 and gave the stock an "overweight" rating in a research report on Friday, November 6th. Finally, Weiss Ratings upgraded STERIS from a "hold (c)" rating to a "hold (c+)" rating in a research note on Monday, November 9th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $283.50.

Get Our Latest Stock Report on STE

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Deroy & Devereaux Private Investment Counsel Inc. boosted its holdings in STERIS by 51.0% in the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 25,355 shares of the medical equipment provider's stock valued at $5,325,000 after purchasing an additional 8,560 shares during the last quarter. Corient Private Wealth LP raised its stake in shares of STERIS by 109.7% during the 2nd quarter. Corient Private Wealth LP now owns 20,978 shares of the medical equipment provider's stock valued at $4,417,000 after buying an additional 10,976 shares during the last quarter. Copeland Capital Management LLC raised its stake in shares of STERIS by 13.7% during the 3rd quarter. Copeland Capital Management LLC now owns 177,778 shares of the medical equipment provider's stock valued at $37,335,000 after buying an additional 21,353 shares during the last quarter. Perpetual Ltd raised its stake in shares of STERIS by 9.5% during the 3rd quarter. Perpetual Ltd now owns 69,157 shares of the medical equipment provider's stock valued at $14,524,000 after buying an additional 5,974 shares during the last quarter. Finally, Squarepoint Ops LLC lifted its holdings in shares of STERIS by 1,373.7% in the 2nd quarter. Squarepoint Ops LLC now owns 41,898 shares of the medical equipment provider's stock valued at $8,822,000 after buying an additional 39,055 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

About STERIS

(Get Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Read More

Insider Buying and Selling by Quarter for STERIS (NYSE:STE)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at STERIS?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for STERIS and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles